But even as Ozempic enters India, there is a growing sense globally that Novo may have already lost the obesity drug war to Mounjaro, Eli Lilly’s blockbuster that has become India’s top-selling drug ...

The actress, 44, shared that she and her chef husband, 45, made the 'difficult decision' to end their marriage after seven ...

The comedian stunned fans with a leggy Valentino mini dress as she shared candid snaps and opened up about her wellness ...

In an interview, Novo Nordisk India’s managing director Vikrant Shrotriya discusses the launch of Ozempic, the company’s ...

The move broadens treatment choices for pediatric patients aged 10 years and older whose diabetes remains uncontrolled with ...

A WOMAN has left people with their jaws on the floor after sharing her epic Mounjaro weight loss journey. Mum Lisa jumped on ...

There has been a seven-fold increase in the number of people using weight loss jabs in the UK over the last year. | ITV News ...

Clinical trial finds 82% of Mounjaro users regain at least 25% of lost weight within one year of quitting the popular ...

We never know what demons other people are fighting, even if we think we see their problems from the outside. Those who ...

TecFut is one of the hallmarks of Julio Casares’ administration, which in the past five years has regularly invited journalists to personally see the equipment and facilities in Cotia. This year, the ...

Dec 12 (Reuters) - The European Medicines ‌Agency's ​committee on Friday ‌recommended extending the use of Eli Lilly's ...

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly.